PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.75
arrow_upward
+1.85%(+0.050) 1D
Oct 9, 3:28:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.70
High
$2.78
Low
$2.69
Mkt. cap
221.57M
Avg. vol.
803.21K
Volume
882.80K
P/E ratio
12.16
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
Open
$2.70
High
$2.78
Low
$2.69
Mkt. cap
221.57M
Avg. vol.
803.21K
Volume
882.80K
P/E ratio
12.16
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
Seeking Alpha
·
37 minutes ago
Digital payments firm OPay applies to list on NYSE
SpaceQ
·
17 minutes ago
NorthStar rings NYSE bell, adds U.S. technical director
The Manila Times
·
33 minutes ago
UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
Yahoo Finance
·
30 minutes ago
2 Nasdaq 100 Stocks to Own for Decades and 1 We Question
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com